Janssen Pharmaceuticals
Overview
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is dedicated to addressing and solving some of the most important unmet medical needs of our time. It specializes in medicines for a variety of diseases and conditions, focusing on therapeutic areas like oncology, immunology, and neuroscience.
Therapeutic areas
FDA compliance signals
8 FDA enforcement records linked to this company.
- 4832024-09-27
Failure to comply with REMS Implementation System
- 4832023-12-14
Scientifically sound laboratory controls
- 4832023-12-14
Cleaning / Sanitizing / Maintenance
- 4832023-12-14
Training , Education , Experience overall
- recall — Class II2018-11-14
Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.
- recall — Class II2018-11-14
Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.
- recall — Class II2015-05-20
Subpotent Drug
- recall — Class II2014-08-13
Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.